-7.1 C
Beijing
Friday, February 6, 2026

Eli Lilly Stock Soars on Robust Sales Outlook Fueled by Weight-Loss Drug Demand

Eli Lilly's stock surges on strong 2026 sales outlook, driven by high demand for its weight-loss drugs Mounjaro and Zepbound. Competitor Novo Nordisk sees stock decline.

Sony Surges Past Expectations: Q3 Earnings Soar 22%, Full-Year Outlook Boosted

Sony reports a 22% surge in Q3 operating profit, exceeding expectations and leading to an upgraded full-year financial outlook, driven by strong performance in gaming and music divisions.

Shell Reports Weakest Quarterly Profit in Nearly Five Years, Yet Boosts Shareholder Returns

Shell reports its weakest quarterly profit in nearly five years but maintains a $3.5 billion buyback and increases its dividend, despite falling oil prices and rising debt.

IMAX Targets $1.2 Billion Year with Strong Film Slate and Global Success

BusinessIMAX Targets $1.2 Billion Year with Strong Film Slate and Global Success

IMAX is on track for a potential $1.2 billion year, according to CEO Rich Gelfond. This would represent the company’s best box office performance, driven by a strong lineup of blockbuster films. Gelfond attributes the expected success to the upcoming slate of major titles, which includes a new “Mission Impossible” movie, a live-action “How to Train Your Dragon,” a new “Jurassic Park” installment, a sequel to “Zootopia,” and the third release in the “Avatar” franchise. The 2025 film calendar is shaping up to be more robust than 2024, which saw a 3.4% decline in box office receipts to $8.74 billion due to fewer theatrical releases and smaller ticket sales.

One of the biggest contributors to IMAX’s box office projection is the Chinese film “Ne Zha 2,” which has already grossed $1.6 billion globally. This marks a historic achievement as the first film to surpass $1 billion in a single country. IMAX has played a significant role in the success of the film, accounting for $135 million of its box office total. Gelfond noted that the company has already surpassed its total box office revenue from China in 2024 within the first six weeks of this year, further bolstering its outlook for 2025. He added that “Ne Zha 2” is consistently performing at a pace of around $100 million per day, with IMAX contributing approximately 13% of the film’s global receipts.

With such a strong film lineup, particularly in international markets, IMAX is poised to see impressive financial results in the coming year. The company’s specialty in high-resolution cameras, projectors, and theaters continues to resonate with audiences seeking a premium cinematic experience, making it well-positioned to benefit from the global box office resurgence.

READ MORE:

Check out our other content

Check out other tags:

Most Popular Articles